Immunodeficiency secondary to biologics

J Allergy Clin Immunol. 2023 Mar;151(3):686-690. doi: 10.1016/j.jaci.2023.01.012. Epub 2023 Jan 24.

Authors

Roxane Labrosse¹, Elie Haddad²

Affiliations

¹ Department of Pediatrics, Immunology and Infectious Diseases, CHU Sainte-Justine, University of Montréal, Montréal, Québec, Canada.
² Department of Pediatrics, Immunology and Infectious Diseases, CHU Sainte-Justine, University of Montréal, Montréal, Québec, Canada; Department of Microbiology, Immunology and Infectious Diseases, CHU Sainte-Justine, University of Montréal, Montréal, Québec, Canada. Electronic address: elie.haddad@umontreal.ca.

PMID: 36706964
DOI: 10.1016/j.jaci.2023.01.012

No abstract available

Keywords: Secondary immunodeficiency; acquired immunodeficiency; biologics; immunomodulatory medications; immunosuppressive medications.

Publication types

Editorial

MeSH terms

Biological Products*
Humans
Immunologic Deficiency Syndromes*
Immunosuppressive Agents

Substances

Biological Products
Immunosuppressive Agents